Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children

References

• Holgate ST, Wenzel S, Postma DS, et al. Asthma. Nat Rev Dis Primers. 2015;1:15025.
   PubMed Web of Science ®Google Scholar
• Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy. 2010;59:469–478.
   Web of Science ®Google Scholar
• Chanez P, Humbert M. Asthma: still a promising future? Eur Respir Rev. 2014;23:405–407.
   PubMedGoogle Scholar
• Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev. 2017;278:162–172.
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Saglani S. Development of allergic immunity in early life. Immunol Rev. 2017;278:101–115.
   PubMed Web of Science ®Google Scholar
• Nakayama T. Introduction to allergic inflammation. Immunol Rev. 2017;278:5–7.
   PubMed Web of Science ®Google Scholar
• Pelaia G, Vatrella A, Busceti MT, et al. Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators Inflamm. 2015;879783.
   Google Scholar
• Hirose K, Iwata A, Tamachi T, et al. Allergic airway inflammation: key players beyond the Th2 cell pathway. Immunol Rev. 2017;278:145–161.
   PubMed Web of Science ®Google Scholar
• Maggi L, Montaini G, Mazzoni A, et al. Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production. J Allergy Clin Immunol. 2017;139:964–976.
   PubMed Web of Science ®Google Scholar
• Saglani S, Lloyd CM. Novel concepts in airway inflammation and remodelling in asthma. Eur Respir J. 2015;46:1796–1804.
   PubMed Web of Science ®Google Scholar
• Pelaia G, Vatrella A, Maselli R Airway remodelling. In: Asthma: targeted biological therapies. Springer International Publishing Switzerland; 2017. p. 17–25.
   Google Scholar
• Saglani S, Payne DN, Zhu J, et al. Early detection of airway remodelling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med. 2007;176:858–864.
   PubMed Web of Science ®Google Scholar
• Payne DN, Rogers AV, Adelroth E, et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med. 2003;167:78–82.
   PubMed Web of Science ®Google Scholar
• Barbato A, Turato G, Baraldo S, et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med. 2006;174:975–981.
   PubMed Web of Science ®Google Scholar
• Martin-Orozco E, Norte-Munoz M, Martinez-Garcia J, et al. Regulatory T cells in allergy and asthma. Front Pediatr. 2017;5:117.
   PubMed Web of Science ®Google Scholar
• Palomares O, Akdis M, Martin-Fontecha M, et al. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev. 2017;278:219–236.
   PubMed Web of Science ®Google Scholar
• Casale T, Stokes JR. Immunotherapy: what lies beyond. J Allergy Clin Immunol. 2014;133:612–619.
   PubMed Web of Science ®Google Scholar
• Tsabouri S, Mavroudi A, Feketea G, et al. Subcutaneous and sublingual immunotherapy in allergic asthma in children. Front Pediatr. 2017;5:82.
   PubMed Web of Science ®Google Scholar
• Dominguez-Ortega J, Delgado J, Blanco C, et al. Specific allergen immunotherapy for the treatment of allergic asthma: a review of current evidence. J Investig Allergol Clin Immunol. 2017;27(Suppl 1):1–35.
   PubMedGoogle Scholar
• Pifferi M, Baldini G, Marrazzini G, et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy. 2002;57:785–790.
   PubMed Web of Science ®Google Scholar
• Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18:693–704.
   PubMed Web of Science ®Google Scholar
• Froidure A, Mouthuy J, Durham SR, et al. Asthma phenotypes and IgE responses. Eur Respir J. 2016;47:304–319.
   PubMed Web of Science ®Google Scholar
• Kaiko GE, Horvat JC, Beagley KW, et al. Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology. 2008;123:326–338.
   PubMed Web of Science ®Google Scholar
• Kallinich T, Beier KC, Wahn U, et al. T-cell co-stimulatory molecules: their role in allergic immune reactions. Eur Respir J. 2007;29:1246–1255.
   PubMed Web of Science ®Google Scholar
• Hammad H, Lambrecht BN. Barrier epithelial cells and the control of type 2 immunity. Immunity. 2015;43:29–40.
   PubMed Web of Science ®Google Scholar
• Morita H, Moro K, Koyasu S. Innate lymphoid cells in allergic and non-allergic inflammation. J Allergy Clin Immunol. 2016;138:1253–1264.
   PubMed Web of Science ®Google Scholar
• Cosmi L, Annunziato F. ILC2 are the earliest recruiters of eosinophils in lungs of allergic asthmatic patients. Am J Respir Crit Care Med. 2017;196:666–668.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 2008;118:3546–3556.
   PubMed Web of Science ®Google Scholar
• Varricchi G, Bagnasco D, Borriello F, et al. Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs. Curr Opin Allergy Clin Immunol. 2016;16:186–200.
   PubMed Web of Science ®Google Scholar
• Halim TY. Group 2 innate lymphoid cells in disease. Int Immunol. 2016;28:13–22.
   PubMed Web of Science ®Google Scholar
• Cavagnero K, Doherty TA. Cytokine and lipid mediator regulation of group 2 innate lymphoid cells (ILCs) in human allergic airway disease. J Cytokine Biol. 2017;2:pii:116.
   Google Scholar
• Peinhaupt M, Sturm EM, Heinemann A. Prostaglandins and their receptors in eosinophil function and as therapeutic targets. Front Med. 2017;4:104.
   PubMed Web of Science ®Google Scholar
• Chen R, Smith SG, Salter B, et al. Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in subjects with asthma. Am J Respir Crit Care Med. 2017;196:700–712.
   PubMed Web of Science ®Google Scholar
• Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2006;24:147–174.
   PubMed Web of Science ®Google Scholar
• Pelaia G, Cuda G, Vatrella A, et al. Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells. Am J Respir Cell Mol Biol. 2003;29:12–18.
   PubMed Web of Science ®Google Scholar
• Makinde T, Murphy RF, Agrawal DK. The regulatory role of TGF-β in airway remodeling. Immunol Cell Biol. 2007;85:348–356.
   PubMed Web of Science ®Google Scholar
• Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med. 2003;198:1875–1886.
   PubMed Web of Science ®Google Scholar
• Roncarolo MG, Gregori S, Battaglia M, et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006;212:28–50.
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–336.
   PubMed Web of Science ®Google Scholar
• Kitagawa Y, Wing JB, Sakaguchi S. Transcriptional and epigenetic control of regulatory T cell development. Prog Mol Biol Transl Sci. 2015;136:1–33.
   PubMed Web of Science ®Google Scholar
• Palomares O, Yaman G, Azkur AK, et al. Role of Treg in immune regulation of allergic diseases. Eur J Immunol. 2010;40:1232–1240.
   PubMed Web of Science ®Google Scholar
• Wink K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008;322:271–275.
   PubMed Web of Science ®Google Scholar
• Meller F, Klunker S, Zimmermann M, et al. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy. 2008;63:1455–1463.
   PubMed Web of Science ®Google Scholar
• Rosser EC, Mauri C. Regulatory B cells: origin, phenotype and function. Immunity. 2015;42:607–612.
   PubMed Web of Science ®Google Scholar
• van de Veen W, Stanic B, Wirz OF, et al. Role of regulatory B cells in immune tolerance to allergens and beyond. J Allergy Clin Immunol. 2016;138:654–665.
   PubMed Web of Science ®Google Scholar
• Stanic B, van de Veen W, Wirz OF, et al. IL-10 overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol. 2015;135:771–780.
   PubMed Web of Science ®Google Scholar
• Braza F, Chesne J, Durand M, et al. A regulatory CD9(+) B-cell subset inhibits HDM-induced allergic airway inflammation. Allergy. 2015;70:1421–1431.
   PubMed Web of Science ®Google Scholar
• Singh A, Carson WF, Secor ER Jr, et al. Regulatory role of B cells in a murine model of allergic airway disease. J Immunol. 2008;180:7318–7326.
   PubMed Web of Science ®Google Scholar
• Natarajan P, Singh A, McNamara JT, et al. Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5+, express TGF-β, and co-localize with CD4+Foxp3+ T cells. Mucosal Immunol. 2012;5:691–701.
   PubMed Web of Science ®Google Scholar
• Zhang HP, Wu Y, Liu J, et al. TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation. Sci Rep. 2013;3:3345.
   PubMed Web of Science ®Google Scholar
• van de Veen W. The role of regulatory B cells in allergen immunotherapy. Curr Opin Allergy Clin Immunol. in press;2017;17:447–452.
   Web of Science ®Google Scholar
• Bousquet J, Lockey R, Malling H. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102:558–562.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2011;127:18–27.
   PubMed Web of Science ®Google Scholar
• Shamji MH, Durham SR. Mechanisms of immunotherapy to aeroallergens. Clin Exp Allergy. 2011;41:1235–1246.
   PubMed Web of Science ®Google Scholar
• Jutel M, Agache I, Bonini S, et al. International consensus on allergen immunotherapy II: mechanisms, standardization and pharmacoeconomics. J Allergy Clin Immunol. 2016;137:358–368.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Casale T, et al. Sublingual immunotherapy. World Allergy Organ J. 2009;2:223–281.
   Google Scholar
• Passalacqua G, Canonica GW. Allergen immunotherapy: history and future developments. Immunol Allergy Clin North Am. 2016;36:1–12.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Akdis M. Advances in allergen immunotherapy: aiming for complete tolerance to allergens. Sci Transl Med. 2015;7:280ps6.
   PubMed Web of Science ®Google Scholar
• Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014;133:621–631.
   PubMed Web of Science ®Google Scholar
• Radulovic S, Jacobson MR, Durham SR, et al. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol. 2008;121:1467–1472.
   PubMed Web of Science ®Google Scholar
• Meller F, Zumkehr J, Klunker S, et al. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med. 2008;205:2887–2898.
   PubMed Web of Science ®Google Scholar
• van de Veen W, Stanic B, Yaman M, et al. IgG4 production is confined to human IL-10 producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 2013;131:1204–1212.
   PubMed Web of Science ®Google Scholar
• Kappen JH, Durham SR, Veen HI, et al. Applications and mechanisms of immunotherapy in allergic rhinitis and asthma. Ther Adv Respir Dis. 2017;11:73–86.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Blesken T, Akdis M, et al. Role of interleukin 10 in specific immunotherapy. J Clin Invest. 1998;102:98–106.
   PubMed Web of Science ®Google Scholar
• Aalberse RC, Stapel SO, Schuurman J, et al. Immunoglobulin G4: an odd antibody. Clin Exp Allergy. 2009;39:469–477.
   PubMed Web of Science ®Google Scholar
• Lao-Araya M, Steveling E, Scadding GW, et al. Seasonal increases in peripheral innate type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. J Allergy Clin Immunol. 2014;134:1193–5.e4.
   PubMed Web of Science ®Google Scholar
• Berings M, Karaaslan C, Altunbulakli C, et al. Advances and highlights in allergen immunotherapy: on the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol. 2017 in press;140:1250–1267.
   PubMed Web of Science ®Google Scholar
• Bohm L, Maxeiner J, Meyer-Martin H, et al. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma. J Immunol. 2015;194:887–897.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. [cited 2017 Aug 12]. Available from: http://www.ginasthma.org/.
   Google Scholar
• Hanci D, Sahin E, Muluk NB, et al. Immunotherapy in all aspects. Eur Arch Otorhinolaryngol. 2016;273:1347–1355.
   PubMed Web of Science ®Google Scholar
• Stringari G, Tripodi S, Caffarelli C, et al. The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever. J Allergy Clin Immunol. 2014;134:75–81.
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Melioli G, Bonifazi F, et al. The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. Allergy. 2013;68:1029–1033.
   PubMed Web of Science ®Google Scholar
• Matricardi PM. Molecular profile clustering of IgE immunotherapy. J Allergy Clin Immunol. 2014;134:75–81.
   PubMedGoogle Scholar
• Canonica GW, Ansotegui IJ, Pawankar R, et al. A WHO – ARIA – GA2LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6:17.
   PubMedGoogle Scholar
• Schubert R, Eickmeier O, Garn H, et al. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy. Int Arch Allergy Immunol. 2009;148:251–260.
   PubMed Web of Science ®Google Scholar
• Agostinis F, Foglia C, Landi M, et al. The safety of sublingual immunotherapy with one or multiple pollen allergens in children. Allergy. 2008;63:1637–1639.
   PubMed Web of Science ®Google Scholar
• Eberle P, Brueck H, Gall R, et al. An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents. Pediatr Allergy Immunol. 2014;25:760–766.
   PubMed Web of Science ®Google Scholar
• Maloney J, Prenner BM, Bernstein DI, et al. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites. Ann Allergy Asthma Immunol. 2016;116:59–65.
   PubMed Web of Science ®Google Scholar
• Bufe A, Eberle P, Franke-Beckmann E, et al. Safety and efficacy in children of an SQ-standardized grass pollen allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol. 2009;123:167–173.
   PubMed Web of Science ®Google Scholar
• Liao W, Hu Q, Shen LL, et al. Sublingual immunotherapy for asthmatic children sensitized to house dust mite: a meta-analysis. Medicine. 2015;94:e701.
   PubMed Web of Science ®Google Scholar
• Nuhoglu Y, Ozumut SS, Ozdemir C, et al. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period. J Investig Allergol Clin Immunol. 2007;17:375–378.
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Yazi D, Gocmen I, et al. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol. 2007;18:508–515.
   PubMed Web of Science ®Google Scholar
• Trebuchon F, Lheritier-Barrand M, David M, et al. Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens. Clin Transl Allergy. 2014;4:15.
   PubMed Web of Science ®Google Scholar
• Valovirta E, Petersen TH, Piotrowska T, et al. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol. 2017 Jul 6. pii: S0091-6749(17)31088-6. doi: 10.1016/j.jaci.2017.06.014. [Epub ahead of print].
   Google Scholar
• Lemberg ML, Eberle P, Shah-Hosseini K. Importance of quality of life for adherence to sublingual immunotherapy. Biomed Res Int. 2016;5186765.
   PubMed Web of Science ®Google Scholar
• Asaria M, Dhami S, van Ree R, et al. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: a systematic overview. Allergy Jul 18. doi: 10.1111/all.13254. [Epub ahead of print].
   Web of Science ®Google Scholar
• Vitale C, Maglio A, Pelaia C, et al. Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy. Expert Opin Phamacother. 2017;18:667–676.
   PubMed Web of Science ®Google Scholar
• Murray CS. Can inhaled corticosteroids influence the natural history of asthma? Curr Opin Allergy Clin Immunol. 2008;8:77–81.
   PubMed Web of Science ®Google Scholar
• Pelaia G, Vatrella A, Maselli R. Asthma: targeted biological therapies. Springer International Publishing Switzerland; 2017.
   Google Scholar
• Kopp MV, Hamelmann E, Bendiks M, et al. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy. Pediatr Allergy Immunol. 2013;24:427–433.
   PubMed Web of Science ®Google Scholar
• Braido F, Corsico A, Rogkakou A, et al. The relationship between allergen immunotherapy and omalizumab for treating asthma. Expert Rev Respir Med. 2015;9:129–134.
   PubMed Web of Science ®Google Scholar